Showing results (361-370 of 5,917) with videos related to
Sort By:
Pageof 592
Arthritis Research & Therapy|April 9, 2020
Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild Safety Adjudication CommitteeGabriella Giancane, Joost F Swart, Elio Castagnola, et al.Arthritis Research & Therapy|May 21, 2020
Overexpression of MIG-6 in the cartilage induces an osteoarthritis-like phenotype in miceMelina Bellini, Michael A Pest, Manuela Miranda-Rodrigues, et al.Arthritis Research & Therapy|June 21, 2020
TNF-α inhibitor therapy can improve the immune imbalance of CD4+ T cells and negative regulatory cells but not CD8+ T cells in ankylosing spondylitisMingcan Yang, Qing Lv, Qiujing Wei, et al.Arthritis Research & Therapy|June 24, 2020
Modifiable environmental exposure and risk of rheumatoid arthritis-current evidence from genetic studiesXia Jiang, Lars AlfredssonArthritis Research & Therapy|June 24, 2020
Parenchymal lung disease in adult onset Still's disease: an emergent marker of disease severity-characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patientsPiero Ruscitti, Onorina Berardicurti, Daniela Iacono, et al.Arthritis Research & Therapy|June 25, 2020
Correction to: Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and TaiwanTsutomu Takeuchi, Yoshiya Tanaka, Sakae Tanaka, et al.Arthritis Research & Therapy|June 12, 2020
Efficacy and safety of sarilumab in combination with csDMARDs or as monotherapy in subpopulations of patients with moderately to severely active rheumatoid arthritis in three phase III randomized, controlled studiesMark C Genovese, Roy Fleischmann, Alan Kivitz, et al.Arthritis Research & Therapy|November 11, 2022
Periostin overexpression in scleroderma cardiac tissue and its utility as a marker for disease complicationsFatima El-Adili, Justin K Lui, Mortada Najem, et al.Arthritis Research & Therapy|October 7, 2005
Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritisYasmina Juarranz, Catalina Abad, Carmen Martinez, et al.Arthritis Research & Therapy|October 7, 2005
Altered dendritic cell distribution in patients with common variable immunodeficiencyJean-François Viallard, Fabrice Camou, Marc André, et al.Pageof 592